Supplemental material
Leukemia & Lymphoma
Volume 63, 2022 - Issue 6
Original Articles
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
, , , , 
, , , , & show all
Olof Beckd Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden;e Unit of Clinical Pharmacology, University Hospital, Stockholm, Swedenhttps://orcid.org/0000-0002-3546-8872View further author information
https://orcid.org/0000-0002-3546-8872View further author information, , Henna-Riikka Junléna Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, Swedenhttps://orcid.org/0000-0003-4749-0601View further author information
https://orcid.org/0000-0003-4749-0601View further author information, , & Björn Engelbrekt Wahlina Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, Swedenhttps://orcid.org/0000-0003-3566-8847View further author information
https://orcid.org/0000-0003-3566-8847View further author information show all